These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 34462267

  • 1. The Interleukin-6/Signal Transducer and Activator of Transcription-3/Cystathionine γ-Lyase Axis Deciphers the Transformation Between the Sensitive and Resistant Phenotypes of Breast Cancer Cells.
    Tan Z, Ge C, Feng D, Xu C, Cao B, Xie Y, Zhou H, Wang G, Aa J.
    Drug Metab Dispos; 2021 Nov; 49(11):985-994. PubMed ID: 34462267
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. SH003 reverses drug resistance by blocking signal transducer and activator of transcription 3 (STAT3) signaling in breast cancer cells.
    Seo HS, Ku JM, Lee HJ, Woo JK, Cheon C, Kim M, Jang BH, Shin YC, Ko SG.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 28864784
    [Abstract] [Full Text] [Related]

  • 6. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
    Kang Y, Park MA, Heo SW, Park SY, Kang KW, Park PH, Kim JA.
    Biochim Biophys Acta; 2013 Mar 22; 1830(3):2638-48. PubMed ID: 23246576
    [Abstract] [Full Text] [Related]

  • 7. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL, Jiang QC, Wang SR.
    Breast Cancer; 2018 Mar 22; 25(2):233-242. PubMed ID: 29181822
    [Abstract] [Full Text] [Related]

  • 8. Cystine supplementation rebalances the redox homeostasis of microenvironment in non-small cell lung cancer cells and reverses their resistance to docetaxel.
    Li SJ, Cao B, Lu ZY, Sun RB, Guo SH, Xie Y, Aa JY, Wang GJ.
    Acta Pharmacol Sin; 2021 Dec 22; 42(12):2132-2143. PubMed ID: 33658706
    [Abstract] [Full Text] [Related]

  • 9. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
    Kanagasabai R, Krishnamurthy K, Druhan LJ, Ilangovan G.
    J Biol Chem; 2011 Sep 23; 286(38):33289-300. PubMed ID: 21784846
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human interleukin 24 reverses Adriamycin resistance in a human breast cancer cell line.
    Amirzada MI, Ma X, Gong X, Chen Y, Bashir S, Jin J.
    Pharmacol Rep; 2014 Oct 23; 66(5):915-9. PubMed ID: 25150001
    [Abstract] [Full Text] [Related]

  • 11. Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp.
    Zhang X, Xiao W, Wang L, Tian Z, Zhang J.
    PLoS One; 2011 Oct 23; 6(6):e20965. PubMed ID: 21677772
    [Abstract] [Full Text] [Related]

  • 12. Sulfur amino acid metabolism in doxorubicin-resistant breast cancer cells.
    Ryu CS, Kwak HC, Lee KS, Kang KW, Oh SJ, Lee KH, Kim HM, Ma JY, Kim SK.
    Toxicol Appl Pharmacol; 2011 Aug 15; 255(1):94-102. PubMed ID: 21703291
    [Abstract] [Full Text] [Related]

  • 13. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
    Zhang W, Guo J, Li S, Ma T, Xu D, Han C, Liu F, Yu W, Kong L.
    Sci Rep; 2017 Apr 11; 7():46352. PubMed ID: 28397855
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cystathionine: A novel oncometabolite in human breast cancer.
    Sen S, Kawahara B, Mahata SK, Tsai R, Yoon A, Hwang L, Hu-Moore K, Villanueva C, Vajihuddin A, Parameshwar P, You M, Bhaskar DL, Gomez O, Faull KF, Farias-Eisner R, Chaudhuri G.
    Arch Biochem Biophys; 2016 Aug 15; 604():95-102. PubMed ID: 27311614
    [Abstract] [Full Text] [Related]

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C, Guan X, Xue H, Wang P, Wang M, Gai X.
    Pathol Res Pract; 2017 Jul 15; 213(7):848-853. PubMed ID: 28554760
    [Abstract] [Full Text] [Related]

  • 17. Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells.
    Ryu CS, Kwak HC, Lee JY, Oh SJ, Phuong NT, Kang KW, Kim SK.
    Biochem Pharmacol; 2013 Jan 15; 85(2):197-206. PubMed ID: 23123664
    [Abstract] [Full Text] [Related]

  • 18. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
    Chen L, Li X, Liu L, Yu B, Xue Y, Liu Y.
    Oncol Rep; 2015 Mar 15; 33(3):1465-74. PubMed ID: 25585997
    [Abstract] [Full Text] [Related]

  • 19. Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells.
    Chadderton A, Villeneuve DJ, Gluck S, Kirwan-Rhude AF, Gannon BR, Blais DE, Parissenti AM.
    Breast Cancer Res Treat; 2000 Feb 15; 59(3):231-44. PubMed ID: 10832593
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
    Liu Y, Liu X, Yang S.
    Biol Pharm Bull; 2021 Jun 01; 44(6):861-868. PubMed ID: 33828027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.